Brukinsa and Gabapentin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Brukinsa (zanubrutinib) and Gabapentin (gabapentin). Common drug interactions include asthenia among females and acute myocardial infarction among males.

The phase IV clinical study analyzes what interactions people have when they take Brukinsa and Gabapentin. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Brukinsa?

Brukinsa has active ingredients of zanubrutinib. eHealthMe is studying from 1,334 Brukinsa users. Check the latest studies of Brukinsa.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,983 Gabapentin users. Check the latest studies of Gabapentin.

On Jul, 04, 2026

19 people who take Brukinsa and Gabapentin together, and have interactions are studied.

Brukinsa and Gabapentin drug interactions.

What are the common drug interactions of Brukinsa and Gabapentin, by gender? *:

female:

Asthenia (weakness)
Chills (felling of cold)
Constipation
Diarrhoea
Lactose intolerance (inability to digest lactose)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Pruritus (severe itching of the skin)
Sneezing
Urticaria (rash of round, red welts on the skin that itch intensely)
White blood cell count increased

male:

Acute myocardial infarction (acute heart attack)
Erythema (redness of the skin)
Haematuria (presence of blood in urine)
Mobility decreased (ability to move is reduced)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Oedema peripheral (superficial swelling)
Pain in extremity
Petechiae (a small red or purple spot caused by bleeding into the skin)
Skin disorder (skin disease)
Skin warm

What are the common drug interactions of Brukinsa and Gabapentin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Chills (felling of cold)
Constipation
Petechiae (a small red or purple spot caused by bleeding into the skin)
Pruritus (severe itching of the skin)
Skin disorder (skin disease)
Skin warm
Sneezing
Urticaria (rash of round, red welts on the skin that itch intensely)
White blood cell count increased
Diarrhoea

What are the existing conditions these people have? *

Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 7 people, 36.84%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 4 people, 21.05%
Dizziness: 3 people, 15.79%
Stress And Anxiety: 2 people, 10.53%
Non-Hodgkin's Lymphoma Stage Iv (malignant (cancer) cells form in the lymph system- stageiv): 2 people, 10.53%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 10.53%
Thyroid Diseases: 2 people, 10.53%
Muscle Spasms (muscle contraction): 2 people, 10.53%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 2 people, 10.53%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Brukinsa and Gabapentin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously